Post-hoc analyses from the trial also showed improvements in cardiometabolic risk factors, including blood pressure, cholesterol, and C-reactive protein
The main risks include dangerous drops in blood glucose (hypoglycaemia), severe dehydration and electrolyte imbalances, acute kidney injury, excessive weight loss with muscle wasting, nutritional deficiencies, and intensified gastrointestinal side effects such as nausea and vomiting
Injections are well-tolerated and administered by licensed medical professionals
To view or add a comment, sign in The Economic Case for PBM Can light therapy save hospital costs
One possibility would be combining GHK with antioxidants, such as the mitochondrial targeted antioxidant SS31 [23], given the role of redox imbalance in persistent lung fibrosis [15]
As the dosage reaches its therapeutic level, the effects on weight loss become more pronounced